Physician-initiated Medication Review in a Type 2 Diabetes Outpatient Clinic

Bispebjerg Hospital

Status: Enrolling

Conditions: Polypharmacy

Treatments: Other: Standard care; Other: Medication review

Study type: Interventional

Funder types: Other

Identifiers

NCT05501223

P-2020-1012

Details and patient eligibility

About

Aiming to reduce polypharmacy in patients with type 2 diabetes by using physician-initiated medication reviews.

Full description

Patients will be randomised to either standard care(annual visit at outpatient clinic) or standard care plus an intervention. The intervention is a medication consultation of 30-60 minutes that consist of a medication review and increased cross-sectoral communication. Follow-up is 6 months. Primary outcome are number of medications used, secondary outcomes are health related quality of life and persistance of medication changes.

Enrollment: 50 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

1. DM2
2. 12 medications in the central prescription list

Exclusion criteria

1. inability to give written consent (e.g., inability to understand the intervention or language barriers);
2. active cancer or palliative treatment;
3. admitted to the hospital.

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

50 participants in 2 patient groups

Intervention

Other group

Description:

Standard care + medication review

Treatment:

Other: Standard care

Other: Medication review

Control

Other group

Description:

Standard care

Treatment:

Other: Standard care